SCHEMBL9946078

SCHEMBL9946078

CB(C)c1ccc(OCc2ccc(C)cc2)cc1

nearest known ligand 0.56

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MAOB P27338 4/20 0.56
PARP10 Q53GL7 1/20 0.54
NPC1 O15118 3/20 0.53
RAB9A P51151 3/20 0.53
CASP3 P42574 1/20 0.53
SMN1; SMN2 Q16637 1/20 0.53
SENP8 Q96LD8 1/20 0.53
SENP7 Q9BQF6 1/20 0.53
SENP6 Q9GZR1 1/20 0.53
HRH3 Q9Y5N1 2/20 0.51
ALDH1A1 P00352 1/20 0.51
MAPT P10636 1/20 0.51
MAPK1 P28482 1/20 0.51
APP P05067 4/20 0.47
HPGD P15428 1/20 0.44
MAOA P21397 1/20 0.44
AGXT P21549 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8929713 0.86 MAOB (0.69) MAOBPARP10NPC1RAB9ACASP3
SCHEMBL8930213 0.86 MAOB (0.69) MAOBPARP10NPC1RAB9ACASP3
SCHEMBL891195 0.86 MAOB (0.69) MAOBPARP10NPC1RAB9ACASP3
SCHEMBL762195 0.86 MAOB (0.69) MAOBPARP10NPC1RAB9ACASP3
SCHEMBL12270437 0.86 MAOB (0.57) MAOBPARP10NPC1RAB9ACASP3
SCHEMBL9946049 0.84 MAOB (0.61) MAOBPARP10NPC1RAB9ACASP3
SCHEMBL2553625 0.84 MAOB (0.58) MAOBPARP10NPC1RAB9ACASP3
SCHEMBL16687435 0.84 MAOB (0.58) MAOBPARP10NPC1RAB9ACASP3
SCHEMBL9946052 0.83 LMNA (0.60) MAOBPARP10NPC1RAB9ASMN1; SMN2
SCHEMBL9946094 0.82 LPL (0.47) MAOBSENP8SENP7SENP6HRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120149693-A1 THERAPEUTIC COMPOUNDS UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) 2012-06-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120149693-A1 THERAPEUTIC COMPOUNDS HTR2C, GRK2, GRK3 MAOB 780/4885PARP10 609/4885NPC1 1529/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.